No Data
No Data
MannKind To Present At Oppenheimer Healthcare Life Sciences Conference; Webcast At 11:20 AM ET
Wedbush Initiates MannKind(MNKD.US) With Buy Rating, Announces Target Price $11
Express News | MannKind Corp : Wedbush Initiates Coverage With Outperform Rating; Target Price $11
While Shareholders of MannKind (NASDAQ:MNKD) Are in the Black Over 5 Years, Those Who Bought a Week Ago Aren't so Fortunate
MannKind to Present at Upcoming Investor Conferences
MannKind (MNKD) Receives a Buy From RBC Capital
Stock_Drift OP : $MannKind (MNKD.US)$
下一个十年的雷熊 : Seems favorable. Strange, there isn't much movement ahead of the market![undefined [undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36)